Nanobody-Based Drug Delivery: Emerging Strategies for Targeted Cancer Therapy
International Journal of Nanomedicine · 2026-03 · Volume 21 · 1-47
DOI: 10.2147/ijn.s584604 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-03. Verfasst von Nandan Ghosh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electronic Materials, Devices, and Equipment Engineering, Soonchunhyang University, Asan, 31538, Republic of Korea. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Neoplasms, Drug Delivery Systems, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 307 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Electronic Materials, Devices, and Equipment Engineering, Soonchunhyang University, Asan, 31538, Republic of Korea.
- Department of Chemical Engineering, Soonchunhyang University, Asan, 31538, Republic of Korea.
ORCID-Profile: Mohuya Paul, Jungkyun Im
Zitieren
APA
Ghosh, N., Sepay, N., Paul, M., & Im, J. (2026). Nanobody-Based Drug Delivery: Emerging Strategies for Targeted Cancer Therapy. International Journal of Nanomedicine, Volume 21, 1-47. https://doi.org/10.2147/ijn.s584604
Vancouver
Ghosh N, Sepay N, Paul M, Im J. Nanobody-Based Drug Delivery: Emerging Strategies for Targeted Cancer Therapy. International Journal of Nanomedicine. 2026;Volume 21:1-47. doi:10.2147/ijn.s584604
BibTeX
@article{Ghosh2026,
author = {Ghosh, Nandan and Sepay, Nasim and Paul, Mohuya and Im, Jungkyun},
title = {Nanobody-Based Drug Delivery: Emerging Strategies for Targeted Cancer Therapy},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--47},
doi = {10.2147/ijn.s584604}
}
EUVIMED